Monitoring heart activity with a smart textile chest band

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical evaluation focuses on the Skiin chest band, a smart garment equipped with electronic textile electrodes designed to record electrocardiogram (ECG) signals from the body. Participants will wear the Skiin chest band for 14 days to monitor their heart activity while also using a smartphone application to log any symptoms they experience. The data collected will contribute to the development of new algorithms and tools for detecting and predicting cardiac arrhythmias. This innovative approach aims to enhance ambulatory ECG monitoring through wearable technology.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Being referred to the Partners in Advanced Cardiac Evaluation (PACE Cardiology), and having been prescribed a 14-day ambulatory ECG monitoring by their physician.
* Able to understand and speak English language, enough to provide informed consent.

Exclusion Criteria:

* Age \< 18 years
* Pregnancy
* Cardiovascular Implantable Electronic Devices (CIED), including Implanted cardioverter defibrillator (ICD) or pacemakers
* Absence of chest band that fits the participant's body
* Open wound or dressing on a body part that needs to be in contact with the Skiin garment

Where it's running

• Partners in Advanced Cardiac Evaluation (PACE) Cardiology Clinic
  Newmarket, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Mouhannad Sadek, MD — Partners in Advanced Cardiac Evaluation (PACE)

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Chest-strap ECG wearable vs. traditional patch monitor in active adults

  This study tests whether the Frontier X Plus chest-strap ECG device can capture heart rhythms as well as the MoMe ARC patch in active adults who already need an ambulatory monitor.

  Recruiting at 3 sites Mayo Clinic · Scottsdale, Arizona and 2 other locations · NCT07772817

• BDNF Levels and Atrial Cardiomyopathy in People Having AF Ablation

  This study tests whether circulating BDNF levels are linked to atrial cardiomyopathy in adults having their first ablation for persistent atrial fibrillation.

  Recruiting Centre Hospitalier Universitaire Dijon · Dijon · NCT07648329

• nano-second pulsed field (nsPFA) catheter ablation for paroxysmal atrial fibrillation using the CellFX system

  The study will try the CellFX nano-second pulsed field catheter to treat adults with recurrent, drug-resistant paroxysmal atrial fibrillation.

  Recruiting Pulse Biosciences, Inc. · Prague, Roentgenova · NCT07018596

• Using a new catheter system to treat atrial fibrillation

  This study is testing a new catheter system to see if it safely helps people with paroxysmal atrial fibrillation feel better after treatment.

  Recruiting at 2 sites Pulse Biosciences, Inc. · Hasselt and 2 other locations · NCT06696170

• Ablation of focal activation in atrial fibrillation

  This study is testing a new method to find specific electrical signals that may be causing ongoing atrial fibrillation in patients, to see if targeting these signals can improve their treatment.

  Recruiting Imperial College London · London · NCT06402617

• HeartWatch vs Holter: A Longer-Term Arm Monitors Heart Rhythm

  This study tests whether the HeartWatch arm monitor can match or improve on Holter monitoring for detecting rhythm problems in adults with suspected AF and other arrhythmias.

  Recruiting HelpWear Inc. · Calgary, Alberta · NCT06164808

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.